Elsevier

Clinica Chimica Acta

Volume 166, Issue 1, 30 June 1987, Pages 45-56
Clinica Chimica Acta

Age-related accumulation of phytanic acid in plasma from patients with the cerebro-hepato-renal (Zellweger) syndrome

https://doi.org/10.1016/0009-8981(87)90193-8Get rights and content

Abstract

Plasma samples from several Zellweger patients were found to contain elevated phytanic acid levels. It was subsequently found that the level of phytanic acid in plasma from Zellweger patients depends upon the age of the patients at the time of sampling. In patients 17 weeks of age or younger, plasma phytanic acid levels were found to be normal, whereas in patients 40 weeks of age or older plasma phytanic acid levels were found to be elevated. The relationship between the age of the patients at sampling and the level of phytanic acid in the patients' plasma is probably the resultant of dietary intake of phytanic acid combined with a defective catabolism of this compound.

References (30)

  • O Stokke et al.

    Refsum's disease, adrenoleukodystrophy, and the Zellweger syndrome

    Scand J Clin Lab Invest

    (1984)
  • BT Poil-Thé et al.

    Biochemical findings suggesting multiple peroxisomal dysfunction

    J Inter Metab Dis

    (1986)
  • A Poulos et al.

    Plasma and skin fibroblasts C26 fatty acids in infantile Refsum's disease

    Neurology

    (1984)
  • A Poulos et al.

    Identification of 3α,7α,12α-trihydroxy-5β-cholestan-26-oic acid, an intermediate in cholic acid synthesis, in the plasma of patients with infantile Refsum's disease

    J Inher Metab Dis

    (1985)
  • RI Kelley

    The cerebro-hepato-renal syndrome of Zellweger, morphologic and metabolic aspects

    Am J Med Gen

    (1983)
  • Cited by (27)

    • Phytol in a pharma-medico-stance

      2015, Chemico-Biological Interactions
      Citation Excerpt :

      In addition, PYT has also been previously reported to have antispasmodic activity [4]. PA along with its α-oxidation product called pristanic acid [98,99] is apparently accumulated in patients suffering from RD [100,101], SLS [40,102], RCDP [103–107], chronic polyneuropathy with bilateral shortening of the proximal phalanges and ichthyosis [108], progressive ataxia and disarthria [109], infantile RD, ZDHA or neonatal adrenoleucodystrophy with characteristic incongruities [102,104,110–112] and RBC in great apes [113]. Although the methyl group at C3 position of PA makes it difficult for β-oxidation [114,115] but the NADPH dependent Ω-oxidation [116] suggests PA as an important biomarker to the above-mentioned patients [43,113,117–120].

    • Comparative profiling of the peroxisomal proteome of wildtype and Pex7 knockout mice by quantitative mass spectrometry

      2012, International Journal of Mass Spectrometry
      Citation Excerpt :

      As a consequence, the import of the mammalian PTS2 proteins acetyl-Coenzyme A (CoA) acyltransferase (Acaa1)[32], alkylglycerone phosphate synthase (Agps)[33], and phytanoyl-CoA hydroxylase (Phyh) [34–36] is abolished. Impaired import of Phyh and Agps leads to the accumulation of phytanic acid [37] and deficient synthesis of plasmalogens [38,39], respectively. Interestingly, deficient import of Acaa1 did not affect fatty acid β-oxidation in RCDP type 1 patients [14,40,41].

    • Mechanisms of action of extracorporeal photochemotherapy

      2003, Transfusion and Apheresis Science
    • Phytanic acid α-oxidation in peroxisomal disorders: Studies in cultured human fibroblasts

      1997, Biochimica et Biophysica Acta - Molecular Basis of Disease
    View all citing articles on Scopus
    View full text